STTK
USDShattuck Labs Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$1.960
High
$2.075
Low
$1.858
Volume
0.10M
Company Fundamentals
Market Cap
92.5M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.81M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Wedbush Initiates Coverage On Shattuck Labs with Outperform Rating, Announces Price Target of $4
Wedbush analyst David Nierengarten initiates coverage on Shattuck Labs with a Outperform rating and announces Price Target of $4.
Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors
— Aggregate net proceeds from private placement expected to fund SL-325 through multiple Phase 2 clinical trials, including in Inflammatory Bowel Disease (IBD) and potentially another autoimmune disease — — Pro forma
Shattuck Labs Announces IND for SL-325 Is in Effect for the Treatment of Inflammatory Bowel Disease
– SL-325 is a potentially first-in-class DR3 antagonist antibody being developed for the treatment of Inflammatory Bowel Disease (IBD) and other inflammatory and immune-mediated diseases – – The Company is on track to
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.